» Articles » PMID: 37404378

Genetic Distinction Between Functional Tissue-resident and Conventional Natural Killer Cells

Overview
Journal iScience
Publisher Cell Press
Date 2023 Jul 5
PMID 37404378
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-residential natural killer (trNK) cells act as pioneering responders during infectious challenges. However, their discrimination with conventional NK (cNK) cells is still an issue. Through an integrative transcriptome comparison of the two NK subgroups from different tissues, we have defined two genesets capable of efficiently distinguishing them. Based on the two genesets, a fundamental difference between the activation of trNK and cNK is identified and further confirmed. Mechanistically, we have discovered a particular role of chromatin landscape in regulating the trNK activation. In addition, IL-21R and IL-18R are respectively highly expressed by trNK and cNK, indicating a role of cytokine milieu in determining their differential activation. Indeed, IL-21 is particularly critical in accessorily promoting trNK activation using a bunch of bifunctional transcription factors. Together, this study sheds light on the difference between trNK and cNK, which will further expand our knowledge about their distinct functionalities during immune responses.

Citing Articles

Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.

Nayak I, Biondo R, Stewart W, Fulton R, Moker N, Zhang C Immunol Cell Biol. 2025; 103(2):192-212.

PMID: 39865344 PMC: 11792776. DOI: 10.1111/imcb.12848.


Tissue-resident immune cells: from defining characteristics to roles in diseases.

Li J, Xiao C, Li C, He J Signal Transduct Target Ther. 2025; 10(1):12.

PMID: 39820040 PMC: 11755756. DOI: 10.1038/s41392-024-02050-5.


Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications.

Si C, Gao J, Ma X Mol Cancer. 2024; 23(1):134.

PMID: 38951879 PMC: 11218398. DOI: 10.1186/s12943-024-02045-4.

References
1.
Hsu J, Sage J . Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle. 2016; 15(23):3183-3190. PMC: 5176148. DOI: 10.1080/15384101.2016.1234551. View

2.
Nixon B, Chou C, Krishna C, Dadi S, Michel A, Cornish A . Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Sci Immunol. 2022; 7(70):eabi8642. PMC: 9233921. DOI: 10.1126/sciimmunol.abi8642. View

3.
Gasteiger G, Fan X, Dikiy S, Lee S, Rudensky A . Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science. 2015; 350(6263):981-5. PMC: 4720139. DOI: 10.1126/science.aac9593. View

4.
Feng Y, Desjardins C, Cooper O, Kontor A, Nocco S, Naya F . EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity. PLoS One. 2015; 10(5):e0127641. PMC: 4444265. DOI: 10.1371/journal.pone.0127641. View

5.
Ducimetiere L, Lucchiari G, Litscher G, Nater M, Heeb L, Gonzalo Nunez N . Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci U S A. 2021; 118(27). PMC: 8271692. DOI: 10.1073/pnas.2026271118. View